Peter A Thompson's Net Worth
Peter A Thompson's net worth is estimated to be at least $63,930,535.00 as of 04/28/2026. CoreStreet's estimation of Peter A Thompson's net worth is based on their sale of stock and current holding of stock.
Peter A Thompson is Director at Sionna Therapeutics, Inc. Common Stock. They have executed at least 21 trades of stock as per SEC Form 4 filings. Their most recent trade was for 2,948 units of SION stock on 04/18/2026. Their biggest sale was on 04/15/2026 when they sold 235,863 units of Sionna Therapeutics, Inc. Common Stock stock for $10,528,924.32. They typically trade 2 times per year.
Total value of insider buys:
- $19,087,992.54
Total value of insider sells:
- $44,842,542.46
Most recent insider trade:
- April 18, 2026
Peter A Thompson's Insider Trading History
| Sionna Therapeutics, Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 18, 2026 | Director | 2,948 | $44.52 | Sell | $131,244.96 |
April 17, 2026 | Director | 52,397 | $44.68 | Sell | $2,341,097.96 |
April 16, 2026 | Director | 226,906 | $45.34 | Sell | $10,287,918.04 |
April 15, 2026 | Director | 235,863 | $44.64 | Sell | $10,528,924.32 |
April 14, 2026 | Director | 47,814 | $44.51 | Sell | $2,128,201.14 |
Feb. 3, 2026 | Director | 29,063 | $44.58 | Sell | $1,295,628.54 |
Feb. 2, 2026 | Director | 1,890 | $44.57 | Sell | $84,237.30 |
| Corvus Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 27, 2025 | Director | 1,176,332 | $4.16 | Sell | $4,893,541.12 |
June 27, 2019 | Director | 32,923 | $3.34 | Buy | $109,962.82 |
June 10, 2016 | Director | 50,000 | $12.96 | Buy | $648,000.00 |
May 19, 2016 | Director | 6,800 | $11.77 | Buy | $80,036.00 |
March 29, 2016 | Director | 550,000 | $15.00 | Buy | $8,250,000.00 |
| Silverback Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 26, 2024 | Director | 83,695 | $13.00 | Sell | $1,088,035.00 |
Aug. 23, 2024 | Director | 69,500 | $13.03 | Sell | $905,585.00 |
Aug. 21, 2024 | Director | 407,700 | $13.56 | Sell | $5,528,412.00 |
| Edgewise Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 23, 2024 | Director | 454,545 | $11.00 | Buy | $4,999,995.00 |
Sept. 16, 2022 | Director | 484,496 | $10.32 | Buy | $4,999,998.72 |
| Alpine Immune Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 27, 2023 | Director | 181,498 | $19.96 | Sell | $3,622,700.08 |
| Adaptimmune Therapeutics Plc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 4, 2018 | Director | 17,100 | $13.57 | Sell | $232,047.00 |
May 30, 2018 | Director | 121,000 | $13.52 | Sell | $1,635,920.00 |
May 14, 2018 | Director | 10,300 | $13.50 | Sell | $139,050.00 |